Clinical Trials Browser

Terminated × Pancreatic Neoplasms × Filgrastim × Clear all

NCT01822756 2018-02-12

An Open-Label Study of Ruxolitinib Given With Chemotherapy in Patients With Advanced Solid Tumors

Phase 1 Terminated

42 enrolled 14 charts

Gastrointestinal

Pancreatic Neoplasms